Last Posted: Jun-24-2019 11AM
Last Posted: Jun 24, 2019
- Big Data Scientist Training Enhancement Program (BD-STEP)
NCI, 2019 - [Breast and Endocrine Tumor Genomic Medicine for Endocrine Tumor].
Saeki Toshiaki et al. Gan to kagaku ryoho. Cancer & chemotherapy 2018 Dec 45(12) 1710 - [I. Genomic Medicine in Thyroid Cancer].
Enokida Tomohiro et al. Gan to kagaku ryoho. Cancer & chemotherapy 2018 Dec 45(12) 1711-1715 - [II. Medical Genomics for Breast Cancer].
Aruga Tomoyuki et al. Gan to kagaku ryoho. Cancer & chemotherapy 2018 Dec 45(12) 1716-1719 - [III. Hereditary Breast and/or Ovarian Cancer Syndrome].
Sugitani Ikuko et al. Gan to kagaku ryoho. Cancer & chemotherapy 2018 Dec 45(12) 1720-1724 - [Validation of a 4-Item-Questionnaire on Familial and Hereditary Colorectal Cancer Risk in General Practice].
Koné I et al. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) 2018 Mar 80(3) 266-269 - [Who Should Provide Persons with Familial Risk of Colorectal Cancer with Information on Early Detection? - The View of those Affected].
Plath Jasper et al. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)) 2018 Oct 80(10) 878-881 - Association of CYP2C19*2 and ALDH1A1*1/*2 variants with disease outcome in breast cancer patients: results of a global screening array.
Kalra Sourav et al. European journal of clinical pharmacology 2018 Oct 74(10) 1291-1298 - DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis.
Henricks Linda M et al. The Lancet. Oncology 2018 19(11) 1459-1467 - Familial adenomatosis of the colon: current state of the problem.
Kit O I et al. Terapevticheskii arkhiv 2018 Feb 90(2) 65-68
No hay comentarios:
Publicar un comentario